Moderna, Inc. (MRNA) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $868.00M | -40.7% |
| 2024 | $1.46B | -68.8% |
| 2023 | $4.69B | -13.3% |
| 2022 | $5.42B | +107.0% |
| 2021 | $2.62B | +32612.5% |
| 2020 | $8.00M | — |
| 2019 | $0 | — |
| 2018 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $868.00M | -40.7% |
| 2024 | $1.46B | -68.8% |
| 2023 | $4.69B | -13.3% |
| 2022 | $5.42B | +107.0% |
| 2021 | $2.62B | +32612.5% |
| 2020 | $8.00M | — |
| 2019 | $0 | — |
| 2018 | $0 | — |